CVE-2022-47376

Description

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Categories

7.3
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory bd.com
Affected: n/a Alaris Infusion Central
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-47376?
CVE-2022-47376 has been scored as a high severity vulnerability.
How to fix CVE-2022-47376?
To fix CVE-2022-47376, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-47376 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-47376 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-47376?
CVE-2022-47376 affects n/a Alaris Infusion Central.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.